Cargando…

The use of the rapid osmotic fragility test as an additional test to diagnose canine immune-mediated haemolytic anaemia

BACKGROUND: Diagnosing canine immune-mediated haemolytic anaemia (IMHA) is often challenging because all currently available tests have their limitations. Dogs with IMHA often have an increased erythrocyte osmotic fragility (OF), a characteristic that is sometimes used in the diagnosis of IMHA. Sinc...

Descripción completa

Detalles Bibliográficos
Autores principales: Paes, Geert, Paepe, Dominique, Meyer, Evelyne, Kristensen, Annemarie T, Duchateau, Luc, Campos, Miguel, Daminet, Sylvie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3816578/
https://www.ncbi.nlm.nih.gov/pubmed/24160183
http://dx.doi.org/10.1186/1751-0147-55-74
_version_ 1782477957110956032
author Paes, Geert
Paepe, Dominique
Meyer, Evelyne
Kristensen, Annemarie T
Duchateau, Luc
Campos, Miguel
Daminet, Sylvie
author_facet Paes, Geert
Paepe, Dominique
Meyer, Evelyne
Kristensen, Annemarie T
Duchateau, Luc
Campos, Miguel
Daminet, Sylvie
author_sort Paes, Geert
collection PubMed
description BACKGROUND: Diagnosing canine immune-mediated haemolytic anaemia (IMHA) is often challenging because all currently available tests have their limitations. Dogs with IMHA often have an increased erythrocyte osmotic fragility (OF), a characteristic that is sometimes used in the diagnosis of IMHA. Since the classic osmotic fragility test (COFT) is time-consuming and requires specialized equipment, an easy and less labour-intensive rapid osmotic fragility test (ROFT) has been used in some countries, but its diagnostic value has not yet been investigated. This study aimed to evaluate erythrocyte osmotic fragility in dogs with and without IMHA, to compare results of the classic (COFT) and rapid (ROFT) test and to assess the value of the ROFT as diagnostic test for canine IMHA. Nineteen dogs with IMHA (group 1a), 21 anaemic dogs without IMHA (group 1b), 8 dogs with microcytosis (group 2), 13 hyperlipemic dogs (group 3), 10 dogs with lymphoma (group 4), 8 dogs with an infection (group 5) and 13 healthy dogs (group 6) were included. In all dogs, blood smear examination, in-saline auto-agglutination test, Coombs’ test, COFT and ROFT were performed. In the COFT, OF5, OF50 and OF90 were defined as the NaCl concentrations at which respectively 5, 50 and 90% of erythrocytes were haemolysed. RESULTS: Compared with healthy dogs, OF5 and OF50 were significantly higher in group 1a (P < 0.001) and OF5 was significantly higher in group 3 (P = 0.0266). The ROFT was positive in 17 dogs with IMHA, 10 hyperlipemic dogs, one anaemic dog without IMHA and one healthy dog. CONCLUSIONS: Osmotic fragility was increased in the majority of dogs with IMHA and in dogs with hyperlipidemia, but not in dogs with microcytosis, lymphoma or an infection. Although more detailed information was obtained about the osmotic fragility by using the COFT, the COFT and ROFT gave similar results. The ROFT does not require specialized equipment, is rapid and easy to perform and can be used easily in daily practice. Although, the ROFT cannot replace other diagnostic tests, it may be a valuable additional tool to diagnose canine IMHA.
format Online
Article
Text
id pubmed-3816578
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-38165782013-11-05 The use of the rapid osmotic fragility test as an additional test to diagnose canine immune-mediated haemolytic anaemia Paes, Geert Paepe, Dominique Meyer, Evelyne Kristensen, Annemarie T Duchateau, Luc Campos, Miguel Daminet, Sylvie Acta Vet Scand Research BACKGROUND: Diagnosing canine immune-mediated haemolytic anaemia (IMHA) is often challenging because all currently available tests have their limitations. Dogs with IMHA often have an increased erythrocyte osmotic fragility (OF), a characteristic that is sometimes used in the diagnosis of IMHA. Since the classic osmotic fragility test (COFT) is time-consuming and requires specialized equipment, an easy and less labour-intensive rapid osmotic fragility test (ROFT) has been used in some countries, but its diagnostic value has not yet been investigated. This study aimed to evaluate erythrocyte osmotic fragility in dogs with and without IMHA, to compare results of the classic (COFT) and rapid (ROFT) test and to assess the value of the ROFT as diagnostic test for canine IMHA. Nineteen dogs with IMHA (group 1a), 21 anaemic dogs without IMHA (group 1b), 8 dogs with microcytosis (group 2), 13 hyperlipemic dogs (group 3), 10 dogs with lymphoma (group 4), 8 dogs with an infection (group 5) and 13 healthy dogs (group 6) were included. In all dogs, blood smear examination, in-saline auto-agglutination test, Coombs’ test, COFT and ROFT were performed. In the COFT, OF5, OF50 and OF90 were defined as the NaCl concentrations at which respectively 5, 50 and 90% of erythrocytes were haemolysed. RESULTS: Compared with healthy dogs, OF5 and OF50 were significantly higher in group 1a (P < 0.001) and OF5 was significantly higher in group 3 (P = 0.0266). The ROFT was positive in 17 dogs with IMHA, 10 hyperlipemic dogs, one anaemic dog without IMHA and one healthy dog. CONCLUSIONS: Osmotic fragility was increased in the majority of dogs with IMHA and in dogs with hyperlipidemia, but not in dogs with microcytosis, lymphoma or an infection. Although more detailed information was obtained about the osmotic fragility by using the COFT, the COFT and ROFT gave similar results. The ROFT does not require specialized equipment, is rapid and easy to perform and can be used easily in daily practice. Although, the ROFT cannot replace other diagnostic tests, it may be a valuable additional tool to diagnose canine IMHA. BioMed Central 2013-10-25 /pmc/articles/PMC3816578/ /pubmed/24160183 http://dx.doi.org/10.1186/1751-0147-55-74 Text en Copyright © 2013 Paes et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research
Paes, Geert
Paepe, Dominique
Meyer, Evelyne
Kristensen, Annemarie T
Duchateau, Luc
Campos, Miguel
Daminet, Sylvie
The use of the rapid osmotic fragility test as an additional test to diagnose canine immune-mediated haemolytic anaemia
title The use of the rapid osmotic fragility test as an additional test to diagnose canine immune-mediated haemolytic anaemia
title_full The use of the rapid osmotic fragility test as an additional test to diagnose canine immune-mediated haemolytic anaemia
title_fullStr The use of the rapid osmotic fragility test as an additional test to diagnose canine immune-mediated haemolytic anaemia
title_full_unstemmed The use of the rapid osmotic fragility test as an additional test to diagnose canine immune-mediated haemolytic anaemia
title_short The use of the rapid osmotic fragility test as an additional test to diagnose canine immune-mediated haemolytic anaemia
title_sort use of the rapid osmotic fragility test as an additional test to diagnose canine immune-mediated haemolytic anaemia
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3816578/
https://www.ncbi.nlm.nih.gov/pubmed/24160183
http://dx.doi.org/10.1186/1751-0147-55-74
work_keys_str_mv AT paesgeert theuseoftherapidosmoticfragilitytestasanadditionaltesttodiagnosecanineimmunemediatedhaemolyticanaemia
AT paepedominique theuseoftherapidosmoticfragilitytestasanadditionaltesttodiagnosecanineimmunemediatedhaemolyticanaemia
AT meyerevelyne theuseoftherapidosmoticfragilitytestasanadditionaltesttodiagnosecanineimmunemediatedhaemolyticanaemia
AT kristensenannemariet theuseoftherapidosmoticfragilitytestasanadditionaltesttodiagnosecanineimmunemediatedhaemolyticanaemia
AT duchateauluc theuseoftherapidosmoticfragilitytestasanadditionaltesttodiagnosecanineimmunemediatedhaemolyticanaemia
AT camposmiguel theuseoftherapidosmoticfragilitytestasanadditionaltesttodiagnosecanineimmunemediatedhaemolyticanaemia
AT daminetsylvie theuseoftherapidosmoticfragilitytestasanadditionaltesttodiagnosecanineimmunemediatedhaemolyticanaemia
AT paesgeert useoftherapidosmoticfragilitytestasanadditionaltesttodiagnosecanineimmunemediatedhaemolyticanaemia
AT paepedominique useoftherapidosmoticfragilitytestasanadditionaltesttodiagnosecanineimmunemediatedhaemolyticanaemia
AT meyerevelyne useoftherapidosmoticfragilitytestasanadditionaltesttodiagnosecanineimmunemediatedhaemolyticanaemia
AT kristensenannemariet useoftherapidosmoticfragilitytestasanadditionaltesttodiagnosecanineimmunemediatedhaemolyticanaemia
AT duchateauluc useoftherapidosmoticfragilitytestasanadditionaltesttodiagnosecanineimmunemediatedhaemolyticanaemia
AT camposmiguel useoftherapidosmoticfragilitytestasanadditionaltesttodiagnosecanineimmunemediatedhaemolyticanaemia
AT daminetsylvie useoftherapidosmoticfragilitytestasanadditionaltesttodiagnosecanineimmunemediatedhaemolyticanaemia